Coherus BioSciences Inc (CHRS)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: RETAIL-WOMEN'S CLOTHING STORES

450 WINKS LANE BENSALEM, PA 19020

Coherus is a commercial stage biopharmaceutical company with the mission to increase access to cost-effective medicines that can have a major impact on patients' lives and to deliver significant savings to the health care system.

Data as of 2021-10-17 10:05:31 -0400
Market Cap1.3 Billion Shares Outstanding76.48 Million Avg 30-day Volume626.979 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-5.85 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.97132 52-week High/Low22.22 / 12.21 Next Earnings Date2021-11-04 Price to Cash FLow (P/CF) -40.6111
Data provided by IEX Cloud

Are you looking for this stock instead?

View SEC Filings from CHRS instead.

View recent insider trading info

Funds Holding CHRS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CHRS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

438.1 Thousand total shares from 4 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

STILWELL MCDAVID CHIEF FINANCIAL OFFICER

  • Officer
31,611 2021-10-15 4

HEALY JAMES

  • Director
70,086 2021-09-27 2

ANICETTI VINCENT R CHIEF OPERATING OFFICER

  • Officer
274,790 2021-07-06 11

LANFEAR DENNIS M PRESIDENT & CEO

  • Officer
  • Director
1,026,907 2021-06-06 3

MENDELSON ALAN C

  • Director
20,000 2021-05-21 3

STOLPER MARK

  • Director
20,000 2021-05-21 3

VEXLER VLADIMIR CHIEF SCIENTIFIC OFFICER

  • Officer
73,386 2021-04-28 6

VIRET JEAN-FREDERIC CHIEF FINANCIAL OFFICER

  • Officer
61,295 2021-02-01 5

NUSSBAUM SAMUEL R MD

  • Director
0 2021-01-11 1

LAWLIS V BRYAN

  • Director
0 2021-01-11 1

SZELA MARY T

  • Director
0 2021-01-11 1

WAHLSTROM MATS

  • Director
0 2021-01-11 1

TZOUMAKAS KIMBERLY JO

  • Director
0 2021-01-11 1

SATVAT ALI J.

  • Director
0 2020-01-10 0

RICHARDS CHRISTOS

  • Director
0 2020-01-10 0

V-SCIENCES INVESTMENTS PTE LTD

TEMASEK LIFE SCIENCES PRIVATE LTD

FULLERTON MANAGEMENT PTE LTD

TEMASEK HOLDINGS (PRIVATE) LTD

  • 10% Owner
7,381,116 2019-12-30 0

HORTON DARLENE P SEE REMARKS

  • Officer
0 2019-01-18 0

FINCK BARBARA K CHIEF MEDICAL OFFICER

  • Officer
37,043 2018-09-10 0

TROENDLE AUGUST J.

  • Director
1,940,914 2018-02-01 0

WATLER PETER K. CHIEF TECHNICAL OFFICER

  • Officer
5,900 2018-02-01 0

HERMAN ALAN C. CHIEF SCIENTIFIC OFFICER

  • Officer
350,624 2017-12-15 0

FMR LLC

  • SEE REMARK 1
No longer subject to file 2016-08-08 0

LILLY ELI & CO

LILLY VENTURES FUND I LLC

  • FORMER 10% OWNERFORMER 10% OWNER
No longer subject to file 2014-11-12 0

KKR BIOSIMILAR L.P.

KKR BIOSIMILAR GP LLC

KKR FUND HOLDINGS L.P.

KKR FUND HOLDINGS GP LTD

KKR GROUP HOLDINGS L.P.

KKR GROUP LTD

KKR & CO. L.P.

KKR MANAGEMENT LLC

KRAVIS HENRY R

ROBERTS GEORGE R

  • 10% Owner
No longer subject to file 2014-11-12 0

DAIICHI SANKYO COMPANY, LTD

  • FORMER 10% OWNER
No longer subject to file 2014-11-12 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

STILWELL MCDAVID - Officer CHIEF FINANCIAL OFFICER

2021-10-19 19:36:01 -0400 2021-10-15 S 3,507 $16.80 d 31,611 direct

HEALY JAMES - Director see footnote

2021-09-29 20:18:33 -0400 2021-09-29 S 286,076 $16.12 d 0 indirect 2.8002 9.5208 9.5208 6 -1.6179 3

HEALY JAMES - Director see footnote

2021-09-29 20:18:33 -0400 2021-09-28 S 48,329 $17.17 d 286,076 indirect 2.8002 9.5208 9.5208 6 -1.6179 3

HEALY JAMES - Director see footnote

2021-09-29 20:18:33 -0400 2021-09-27 S 100,150 $18.06 d 334,405 indirect 2.8002 9.5208 9.5208 6 -1.6179 3

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
COHERUS BIOSCIENCES INC CHRS 2021-10-21 14:45:03 UTC -0.2429 0.3129 1100000
COHERUS BIOSCIENCES INC CHRS 2021-10-21 14:15:03 UTC -0.2429 0.3129 1100000
COHERUS BIOSCIENCES INC CHRS 2021-10-21 13:45:03 UTC -0.2429 0.3129 1100000
COHERUS BIOSCIENCES INC CHRS 2021-10-21 13:15:02 UTC -0.2429 0.3129 1100000
COHERUS BIOSCIENCES INC CHRS 2021-10-21 12:45:03 UTC -0.2429 0.3129 1100000
COHERUS BIOSCIENCES INC CHRS 2021-10-20 22:15:03 UTC -0.2429 0.3129 1000000
COHERUS BIOSCIENCES INC CHRS 2021-10-20 21:45:03 UTC -0.2429 0.3129 1000000
COHERUS BIOSCIENCES INC CHRS 2021-10-20 21:15:03 UTC -0.2429 0.3129 1000000
COHERUS BIOSCIENCES INC CHRS 2021-10-20 20:45:03 UTC -0.1911 0.2611 1000000
COHERUS BIOSCIENCES INC CHRS 2021-10-20 20:15:03 UTC -0.1911 0.2611 1000000
COHERUS BIOSCIENCES INC CHRS 2021-10-20 19:45:04 UTC -0.1911 0.2611 1000000
COHERUS BIOSCIENCES INC CHRS 2021-10-20 19:15:03 UTC -0.1911 0.2611 1000000
COHERUS BIOSCIENCES INC CHRS 2021-10-20 18:45:03 UTC -0.1911 0.2611 1000000
COHERUS BIOSCIENCES INC CHRS 2021-10-20 18:15:04 UTC -0.1911 0.2611 1000000
COHERUS BIOSCIENCES INC CHRS 2021-10-20 17:45:03 UTC -0.1911 0.2611 1000000
COHERUS BIOSCIENCES INC CHRS 2021-10-20 17:15:03 UTC -0.1911 0.2611 1000000
COHERUS BIOSCIENCES INC CHRS 2021-10-20 16:45:03 UTC -0.1879 0.2579 1000000
COHERUS BIOSCIENCES INC CHRS 2021-10-20 16:15:04 UTC -0.1879 0.2579 1000000
COHERUS BIOSCIENCES INC CHRS 2021-10-20 15:45:03 UTC -0.1879 0.2579 1000000
COHERUS BIOSCIENCES INC CHRS 2021-10-20 15:15:03 UTC -0.1879 0.2579 1000000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Franklin Alternative Strategies Funds- Franklin K2 Alternative Strategies Fund CHRS -32793.0 shares, $-431555.88 2021-05-28 N-PORT
THE LAZARD FUNDS, INC.- Lazard Enhanced Opportunities Portfolio CHRS -6197.0 shares, $-85704.51 2021-06-30 N-PORT
Guidestone Funds- Strategic Alternatives Fund CHRS -16148.0 shares, $-223326.84 2021-06-30 N-PORT
AMERICAN BEACON FUNDS- American Beacon SSI Alternative Income Fund CHRS -22709.0 shares, $-314065.47 2021-06-30 N-PORT
JNL Series Trust- JNL Multi-Manager Alternative Fund CHRS -45153.0 shares, $-624465.99 2021-06-30 N-PORT
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund CHRS -4800.0 shares, $-66384.0 2021-06-30 N-PORT
Morningstar Funds Trust- Morningstar Alternatives Fund CHRS -19523.0 shares, $-254775.15 2021-07-30 N-PORT
Calamos Investment Trust/IL- Calamos Market Neutral Income Fund CHRS -147790.0 shares, $-1928659.5 2021-07-31 N-PORT

Elevate your investments